REMS bone scan study for children with bone conditions
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study uses a new ultrasound technology called REMS to check bone health in children aged 5 to 18 who have conditions that weaken bones. It may help find low bone density without radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 18 years old.
- You have a known health condition that affects your bones (like kidney disease, celiac disease, or others).
- You or your parent/guardian can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart structure and function in children and adults with osteogenesis imperfecta (OI), a condition that affects bones. Researchers want to understand how OI may impact the heart.
This study looks at how well your bones and muscles work together. By measuring your bone density and handgrip strength, doctors can better understand your bone health and find ways to keep you strong as you age.
This trial uses scans like X-rays, CT, or MRI to study how bones and joints age. It aims to understand aging-related problems and may help develop better ways to detect or treat them.
This study tests a new MRI imaging method to detect bone loss (osteoporosis) and muscle loss (sarcopenia) in people with chronic kidney disease. The scan may help doctors catch these problems earlier and manage kidney disease better.
This study compares two ways to measure bone density: a standard X-ray method (DXA) and a newer ultrasound method (REMS). If you are a woman scheduled for a DXA scan, you may help researchers see if the ultrasound test is just as accurate and easier to use.
This study checks if a new MRI scoring system can reliably measure bone inflammation in children with a rare bone disease called CRMO. The goal is to improve how doctors monitor the disease.
Hear when a new Osteogenesis Imperfecta trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.